Improved Detection of Urothelial Carcinoma In Situ With Hexaminolevulinate Fluorescence Cystoscopy

Epstein, 1998, The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee, Am J Surg Pathol, 22, 1435, 10.1097/00000478-199812000-00001 Droller, 2000, Premalignant lesions and carcinoma in situ in bladder neoplasia: introduction and overview, Scand J Urol Nephrol, 205, 62, 10.1080/003655900750016913 Herr, 1997, Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients, World J Urol, 15, 84, 10.1007/BF02201977 Solsona, 2002, Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications, J Urol, 167, 2007, 10.1016/S0022-5347(05)65073-2 Lamm, 2000, Preventing progression and improving survival with BCG maintenance, Eur Urol, 37, 9, 10.1159/000052376 Cheng, 1999, Survival of patients with carcinoma in situ of the urinary bladder, Cancer, 85, 2469, 10.1002/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U Wiener, 1998, Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?, J Urol, 159, 1876, 10.1016/S0022-5347(01)63184-7 Koenig, 1997, Fluorescence detection of bladder carcinoma, Urology, 50, 778, 10.1016/S0090-4295(97)00409-3 Zaak, 2001, Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies, Urology, 57, 690, 10.1016/S0090-4295(00)01053-0 Filbeck, 2002, Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors, J Urol, 168, 67, 10.1016/S0022-5347(05)64833-1 Kloek, 1998, Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin, Photochem Photobiol, 67, 150, 10.1111/j.1751-1097.1998.tb05178.x Marti, 1999, Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach, J Urol, 162, 546, 10.1016/S0022-5347(05)68625-9 Lange, 1999, Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study, Br J Cancer, 80, 185, 10.1038/sj.bjc.6690338 Jichlinski, 2003, Hexyl aminolevulinate fluorescence cystoscopy: a new diagnostic tool for the photodiagnosis of superficial bladder cancer—a multicenter study, J Urol, 170, 226, 10.1097/01.ju.0000060782.52358.04 Sobin, 2002 Armitage, 1971, Statistical inference, 115 Kurth, 2000, Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group, Eur Urol, 37, 1, 10.1159/000052386 Sylvester, 2002, Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials, J Urol, 168, 1964, 10.1016/S0022-5347(05)64273-5 van der Meijden, 1999, Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee, Eur Urol, 35, 267, 10.1159/000019859 Zaak, 2002, Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions, Cancer, 95, 1234, 10.1002/cncr.10821